No association between proton pump inhibitor use and ALS risk: a nationwide nested case–control study
Abstract The use of proton pump inhibitors (PPIs) has been proposed as a potential risk factor for neurodegenerative diseases, but little is known regarding its role in amyotrophic lateral sclerosis (ALS). We therefore aimed to assess the association of PPI use with the subsequent risk of ALS, and p...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2020-08-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-020-70373-8 |